[1]
|
中国炎症性肠病营养诊疗共识[J]. 中华消化病与影像杂志(电子版), 2021, 11(1): 8-15.
|
[2]
|
Ghouri, Y.A., Tahan, V. and Shen, B. (2020) Secondary Causes of Inflammatory Bowel Diseases. World Journal of Gastroenterology, 26, 3998-4017. https://doi.org/10.3748/wjg.v26.i28.3998
|
[3]
|
Sýkora, J., Pomahačová, R., Kreslová, M., et al. (2018) Current Global Trends in the Incidence of Pediatric-Onset Inflammatory Bowel Disease. World Journal of Gastroenter-ology, 24, 2714-2763.
https://doi.org/10.3748/wjg.v24.i25.2741
|
[4]
|
苏晓兰, 国嵩, 张涛, 等. 炎症性肠病诊治现状及中医药治疗特色与优势[J]. 北京中医药, 2020, 39(3): 211-215.
|
[5]
|
徐晓敏, 黄光明. 479例炎症性肠病患者复发相关危险因素临床分析[J]. 胃肠病学, 2015, 20(7): 411-416.
|
[6]
|
Bhattacharya, S. and Cross, R.K. (2019) Is Endoscopic Remis-sion in Ulcerative Colitis Still Good Enough? Inflammatory Bowel Diseases, 25, 1729-1730. https://doi.org/10.1093/ibd/izz177
|
[7]
|
吴开春, 梁洁, 冉志华, 等. 炎症性肠病诊断与治疗的共识意见(2018年•北京) [J]. 中国实用内科杂志, 2018, 38(9): 796-813.
|
[8]
|
郑晓金, 兰辉宇, 郭瑞芳. 174例溃疡性结肠炎患者临床特征分析[J]. 中国实验诊断学, 2022, 26(1): 38-40.
|
[9]
|
Nitzan, O., Elias, M., Peretz, A., et al. (2016) Role of Antibiotics for Treatment of Inflammatory Bowel Disease. World Journal of Gastroenterology, 22, 1078-1087. https://doi.org/10.3748/wjg.v22.i3.1078
|
[10]
|
Cai, R., Cheng, C., Chen, J., et al. (2020) Interactions of Commensal and Pathogenic Microorganisms with the Mucus Layer in the Colon. Gut Microbes, 11, 680-690. https://doi.org/10.1080/19490976.2020.1735606
|
[11]
|
吴泽宇, 桑力轩, 姜敏, 等. 炎症性肠病肠道微生物紊乱研究进展[J]. 中国实用内科杂志, 2020, 40(1): 75-78.
|
[12]
|
Mirsepasi-Lauridsen, H.C., Vallance, B.A., Krogfelt, K.A., et al. (2019) Escherichia coli Pathobionts Associated with Inflammatory Bowel Disease. Clinical Microbiology Reviews, 32, e00060-18. https://doi.org/10.1128/CMR.00060-18
|
[13]
|
王莉, 黄海辉. 炎症性肠病合并艰难梭菌感染的研究进展[J]. 中国感染与化疗杂志, 2020, 20(6): 716-720.
|
[14]
|
Zhang, X.F., Guan, X.X., Tang, Y.J., et al. (2021) Clinical Effects and Gut Microbiota Changes of Using Probiotics, Prebiotics or Synbiotics in Inflammatory Bowel Dis-ease: A Systematic Review and Meta-Analysis. European Journal of Nutrition, 60, 2855-2875. https://doi.org/10.1007/s00394-021-02503-5
|
[15]
|
Arslan, F. and Vahaboğlu, H. (2020) Cytomegalovirus and In-flammatory Bowel Disease, Reconsidering a “Result or Reason Dilemma” in Terms of Viral Pathogenesis and Medical Ethics. Expert Review of Gastroenterology & Hepatology, 14, 307-309. https://doi.org/10.1080/17474124.2020.1745631
|
[16]
|
贾国葆, 吴建胜, 吴亮, 等. 巨细胞病毒在炎症性肠病中的临床意义及其诊治策略[J]. 医学研究杂志, 2017, 46(3): 102-105.
|
[17]
|
李婷, 王巧民. 炎症性肠病与病毒感染的关系[J]. 胃肠病学和肝病学杂志, 2018, 27(7): 813-816.
|
[18]
|
朱姗姗, 林梦月, 陈亚梅. 炎症性肠病患者饮食管理研究进展[J]. 现代消化及介入诊疗, 2021, 26(3): 409-413.
|
[19]
|
Campmans-Kuijpers, M.J.E. and Dijkstra, G. (2021) Food and Food Groups in Inflammatory Bowel Disease (IBD): The Design of the Groningen Anti-Inflammatory Diet (GrAID). Nutrients, 13, 1067.
https://doi.org/10.3390/nu13041067
|
[20]
|
Wark, G., Samocha-Bonet, D., Ghaly, S., et al. (2020) The Role of Diet in the Pathogenesis and Management of Inflammatory Bowel Disease: A Review. Nutrients, 13, 135. https://doi.org/10.3390/nu13010135
|
[21]
|
Jiang, Y., Jarr, K., Layton, C., et al. (2021) Therapeutic Implications of Diet in Inflammatory Bowel Disease and Related Immune-Mediated Inflammatory Diseases. Nutrients, 13, 890. https://doi.org/10.3390/nu13030890
|
[22]
|
邢瑞欣, 王洪乾, 章文慧, 等. 检测炎症性肠病患者血清铜/锌比值的临床意义[J]. 中华消化杂志, 2021, 41(10): 665-670.
|
[23]
|
陈菲, 马鸣. 营养素及特殊饮食治疗与炎症性肠病[J]. 中华临床营养杂志, 2021, 29(3): 171-179.
|
[24]
|
Siva, S., Rubin, D.T., Gulotta, G., et al. (2017) Zinc Deficiency Is Associated with Poor Clinical Outcomes in Patients with Inflammatory Bowel Disease. Inflammatory Bowel Diseases, 23, 152-157.
https://doi.org/10.1097/MIB.0000000000000989
|
[25]
|
Rokkas, T., Portincasa, P. and Koutroubakis, I.E. (2018) Fecal Calprotectin in Assessing Inflammatory Bowel Disease Endoscopic Activity: A Diagnostic Accuracy Me-ta-Analysis. The Journal of Gastrointestinal and Liver Diseases, 27, 299-306. https://doi.org/10.15403/jgld.2014.1121.273.pti
|
[26]
|
Campbell, J.P., Zierold, C., Rode, A.M., et al. (2021) Clinical Performance of a Novel LIAISON Fecal Calprotectin Assay for Differentiation of Inflammatory Bowel Disease From Ir-ritable Bowel Syndrome. Journal of Clinical Gastroenterology, 55, 239-243. https://doi.org/10.1097/MCG.0000000000001359
|
[27]
|
Khaki-Khatibi, F., et al. (2020) Calprotectin in Inflammato-ry Bowel Disease. Clinica Chimica Acta: International Journal of Clinical Chemistry, 510, 556-565. https://doi.org/10.1016/j.cca.2020.08.025
|
[28]
|
徐颜红, 刘婷, 姜云霞, 等. 炎症性肠病复发影响因素的范围综述[J]. 循证护理, 2021, 7(17): 2297-2306.
|
[29]
|
李秀美, 徐宁. 溃疡性结肠炎复发因素的研究现状[J]. 国际医药卫生导报, 2021, 27(21): 3429-3432.
|
[30]
|
Seyedian, S.S., et al. (2019) A Review of the Diagnosis, Prevention, and Treatment Methods of Inflammatory Bowel Disease. Journal of Medicine and Life, 12, 113-122.
|
[31]
|
Oligschlaeger, Y., Yadati, T., Houben, T., et al. (2019) Inflammatory Bowel Disease: A Stressed “Gut/Feeling”. Cells, 8, 659. https://doi.org/10.3390/cells8070659
|
[32]
|
Le Berre, C., Loy, L., Lönnfors, S., et al. (2020) Patients’ Perspectives on Smoking and Inflammatory Bowel Disease: An Online Survey in Collaboration with European Federation of Crohn’s and Ulcerative Colitis Associations. World Journal of Gastroenterology, 26, 4343-4355. https://doi.org/10.3748/wjg.v26.i29.4343
|
[33]
|
黄敏, 周刚, 骆宏. 炎症性肠病与精神心理因素关系的研究现状[J]. 健康研究, 2020, 40(5): 554-557+563.
|
[34]
|
Jordi, S.B.U., Lang, B.M., Auschra, B., et al. (2022) Depressive Symptoms Predict Clinical Recurrence of Inflammatory Bowel Disease. Inflammatory Bowel Diseases, 28, 560-571.
|
[35]
|
龚姗姗, 范一宏, 吕锟, 等. 炎症性肠病心理因素研究进展[J]. 中华消化杂志, 2018, 38(9): 643-645.
|
[36]
|
Rozich, J.J., et al. (2020) Effect of Lifestyle Factors on Outcomes in Patients with Inflammatory Bowel Diseases. The American Journal of Gastroenterology, 115, 832-840. https://doi.org/10.14309/ajg.0000000000000608
|
[37]
|
Mikocka-Walus, A., Pittet, V., Rossel, J.B., et al. (2016) Symptoms of Depression and Anxiety Are Independently Associated with Clin-ical Recurrence of Inflammatory Bowel Disease. Clinical Gastroenterology and Hepatology, 14, 829-835.e1.
|
[38]
|
Ternant, D., Berkane, Z., Picon, L., et al. (2015) Assessment of the Influence of Inflammation and FCGR3A Genotype on Infliximab Pharmacokinetics and Time to Relapse in Patients with Crohn’s Disease. Clinical Pharmacokinetics, 54, 551-562. https://doi.org/10.1007/s40262-014-0225-3
|
[39]
|
Kakuta, Y., Kimura, T., Negoro, K., et al. (2017) Increased Expression of IL12b mRNA Transcribed from the Risk Haplotype for Crohn’s Disease Is a Risk Factor for Disease Relapse in Japanese Patients. Journal of Gastroenterology, 52, 1230-1239. https://doi.org/10.1007/s00535-017-1322-5
|
[40]
|
Gordon, H., Blad, W., Trier Møller, F., et al. (2021) UK IBD Twin Registry: Concordance and Environmental Risk Factors of Twins with IBD. Digestive Diseases and Sciences, 67, 2444-2450.
https://doi.org/10.1007/s10620-021-07080-5
|
[41]
|
Larabi, A., Barnich, N. and Nguyen, H. (2020) New Insights into the Interplay between Autophagy, Gut Microbiota and Inflammatory Responses in IBD. Autophagy, 16, 38-51. https://doi.org/10.1080/15548627.2019.1635384
|
[42]
|
宋杨达, 钟英强. 自噬异常与炎症性肠病发病的关系[J]. 胃肠病学, 2017, 22(5): 304-307.
|